Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

MedGuide: At Last a Long-Sought Opportunity for Patient Education About Prescription Drugs

MedGuide: At Last a Long-Sought Opportunity for Patient Education About Prescription Drugs PROVIDING patients with adequate information concerning the drugs their physicians prescribe has long been the expressed goal of health care professionals from physicians to pharmacists. But it has proved an elusive one. Now, however, the aim has moved measurably closer to achievement. It has been estimated that 30% to 50% of patients do not follow prescribed drug regimens because of lack of information. The result is therapeutic failure and adverse drug events, said Peter H. Rheinstein, MD, director of medicine at the Food and Drug Administration (FDA). He said that among outpatients in the United States, drug-related morbidity and mortality is estimated to cost $76.6 billion annually. Estimates such as this have provided the driving force for moves to provide adequate information to patients about prescription drugs. But for almost 2 decades, none of the groups involved seemed to agree on how, by whom, or in what form this information http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

MedGuide: At Last a Long-Sought Opportunity for Patient Education About Prescription Drugs

Marwick, Charles
JAMA , Volume 277 (12) – Mar 26, 1997
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/medguide-at-last-a-long-sought-opportunity-for-patient-education-about-hcGTuIcMQx

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1997 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1997.03540360017005
Publisher site
See Article on Publisher Site

Abstract

PROVIDING patients with adequate information concerning the drugs their physicians prescribe has long been the expressed goal of health care professionals from physicians to pharmacists. But it has proved an elusive one. Now, however, the aim has moved measurably closer to achievement. It has been estimated that 30% to 50% of patients do not follow prescribed drug regimens because of lack of information. The result is therapeutic failure and adverse drug events, said Peter H. Rheinstein, MD, director of medicine at the Food and Drug Administration (FDA). He said that among outpatients in the United States, drug-related morbidity and mortality is estimated to cost $76.6 billion annually. Estimates such as this have provided the driving force for moves to provide adequate information to patients about prescription drugs. But for almost 2 decades, none of the groups involved seemed to agree on how, by whom, or in what form this information

Journal

JAMA – American Medical Association

Published: Mar 26, 1997

There are no references for this article.